Season 0: Medicare Stars Foundations - Elevating Healthcare Quality: Unleashing Effective Improvement Strategies in Health Plans

Season 1 Ep14 | The Second-Half Playbook: What Medicare Advantage Leaders Should Focus on Before MY2026 Ends

We're halfway through the MY2026 measurement year. At this point, the question isn't "What's our strategy?" That should have been answered months ago. The real question is: Where should we focus the time and resources we have left? In this episode of The Execution Gap, Dr. Peter Saah explores why the second half of the Medicare Advantage measurement year is fundamentally different from the first—and why organizations that continue operating as if it's still January often leave performance on the table. This episode discusses the shift from building capacity to allocating scarce capacity, why activity is no longer enough, and how executive leaders should think differently about chart retrieval, abstraction, provider engagement, and operational priorities as year-end approaches. Key topics include: * Why the management problem changes at mid-year * Activity versus impact * Capacity versus allocation * Why not every chart carries the same value * How to prioritize remaining retrieval opportunities * The executive mindset needed to finish MY2026 strong One principle anchors the entire discussion: The first half of the measurement year builds capacity. The second half allocates scarce capacity. Whether you lead Medicare Advantage Stars, HEDIS operations, quality improvement, medical record retrieval, clinical data exchange (CCD), medical record abstraction, or healthcare operations, this episode offers a strategic framework for maximizing the remainder of the measurement year. Hosted by Dr. Peter Saah, DBA, MBA, CPHQ

Season 1 Ep13 | Three Questions Every Medicare Advantage Executive Should Be Asking Right Now?

The Medicare Advantage Stars program may be entering a new era—one where methodology decisions are increasingly challenged not only through policy channels, but in court. The Clover Health and Elevance Health cases raise important questions for Medicare Advantage executives and quality leaders. But this episode is not about predicting how the courts will rule. Instead, I examine three questions every Medicare Advantage executive should be asking right now: 1. Are we entering a new era of Medicare Advantage governance? 2. Should quality leaders be paying more attention to policy than they did five years ago? 3. What should organizations do while the courts decide? The bigger issue is not one lawsuit or one Star Rating methodology. It is how Medicare Advantage organizations should operate when quality performance, reimbursement, regulation, methodology, and litigation increasingly intersect. For quality leaders, the lesson is clear: execution still matters—but understanding the rules shaping execution matters too. The Execution Gap explores the operational realities behind healthcare quality, evidence, HEDIS, Medicare Advantage, and the work required to turn strategy into defensible execution. #MedicareAdvantage #StarRatings #HealthcareQuality #HEDIS #CMS #QualityImprovement #HealthPlans #TheExecutionGap Find me on Linkedin: https://www.linkedin.com/in/dr-peter-saah-dba-mba-pmp-cphq-0b50a572/

Season 1 Ep 12 | The AI Abstraction Myth: Why Reading Charts Was Never the Hard Part

Artificial intelligence has changed medical record abstraction. But it hasn't changed the most important question. Can your organization trust the evidence it's submitting? In this episode of The Execution Gap, Dr. Peter Saah explores why the future of healthcare quality isn't about reading charts faster—it's about consistently producing evidence that is compliant, audit-ready, and defensible. While AI has become remarkably effective at reviewing medical records and identifying potential evidence, health plans still carry the responsibility of determining what actually satisfies measure specifications. That's where the real work begins. In this episode, you'll learn: * Why reading charts was never the hardest part of abstraction * The critical difference between information and evidence * Why AI identifies findings—but organizations determine whether they count * The Evidence Lifecycle: Information → Candidate Evidence → Trusted Evidence * Why judgment remains essential in AI-assisted abstraction * The operational metrics quality leaders should be measuring * Where the next competitive advantage in Medicare Advantage will come from This episode is for healthcare leaders responsible for HEDIS®, Medicare Stars, Quality Improvement, Risk Adjustment, Medical Record Abstraction, Clinical Operations, and Audit Readiness. Key takeaway: Technology can find information. Organizations create confidence. If you're leading quality operations in an AI-enabled world, this conversation will challenge how you think about abstraction, evidence, and the role of organizational judgment in producing trusted outcomes. Find me on Linkedin - https://www.linkedin.com/in/dr-peter-saah-dba-mba-pmp-cphq-0b50a572/ Pilot inquiries: poderohealth.com/demo Website: poderohealth.com

Season 1 Ep11 | The Retrieval Yield Gap: Why More Charts Don't Mean Better Results

Most health plans measure chart retrieval volume. Very few measure retrieval value. In this episode of The Execution Gap, Dr. Peter Saah introduces the concept of the Retrieval Yield Gap and explains why retrieving more charts does not automatically create more value. A health plan can retrieve thousands of records, hit every retrieval target, and still see little improvement in measure performance, audit readiness, or Stars outcomes. The real question isn't: "How many charts did we retrieve?" The real question is: "What value did those charts create?" In this episode, you'll learn: • Why retrieval volume and retrieval value are not the same thing • The Retrieval Yield framework • The Retrieval Yield Pyramid • How to identify high-value retrieval opportunities • Why some gap closures never survive audit review • The hidden cost of False Yield • How CCD data and medical records play different roles in evidence strategy • Why the same chart is worth more in March than it is in October • The three questions every health plan should ask before retrieving a chart If you're responsible for HEDIS®, Stars, ECDS, quality improvement, risk adjustment, chart retrieval, abstraction operations, or audit readiness, this episode will challenge how you think about evidence collection and performance improvement. Because retrieval volume measures effort. Retrieval yield measures impact. #HealthcareQuality #HEDIS #MedicareAdvantage #StarsRatings #PopulationHealth #RiskAdjustment #ECDS #MedicalRecords #ChartRetrieval #QualityImprovement #HealthcareAnalytics #AuditReadiness #HealthcareOperations

Season 1 Ep10 | Why the Chart You Retrieved May Be More Valuable Than You Think

Episode 11: The Evidence Utilization Gap — Why the Chart You Retrieved May Be More Valuable Than You Think Most Medicare Advantage plans have become very good at retrieving clinical evidence. Very few have become equally good at utilizing it. In this episode of The Execution Gap Podcast, Peter Saah introduces the concept of the Evidence Utilization Gap — the difference between the evidence an organization acquires and the value it actually extracts from that evidence. The central argument is simple: Many plans have already paid for the evidence they need. They simply haven't extracted all the value from it. Peter explores why the chart itself isn't the asset — the evidence inside the chart is — and why treating evidence as a departmental resource instead of an enterprise asset may be creating one of the largest hidden inefficiencies in Medicare Advantage operations today. From HEDIS and risk adjustment to RADV readiness and provider abrasion, this episode examines what happens when organizations focus on evidence acquisition but underinvest in evidence utilization. * Why the chart isn't the asset — the evidence is * The Evidence Utilization Gap and why it matters * The "dual-use chart" and the hidden value inside retrieved records * Why the most expensive chart in healthcare may be the one you've already retrieved but never fully utilized * CMS-HCC V28 and the growing importance of documentation specificity * RADV expansion and the increasing importance of evidence traceability * Why chart retrieval and abstraction should be viewed as enterprise capabilities * The provider abrasion cost of duplicate retrieval workflows * The CFO Test: explaining your evidence workflow to finance leadership * The difference between evidence acquisition and evidence utilization * Why the organizations that win may not retrieve the most charts — they may simply extract the most value from every chart they retrieve Key Takeaways: Retrieval is an activity. Evidence utilization is an outcome. The plans that perform best over the next decade may not be the ones retrieving the most charts. They may be the ones extracting the most value from every chart they retrieve. Pilot inquiries: poderohealth.com/demo Connect with Peter Saah on LinkedIn: https://www.linkedin.com/in/dr-peter-saah-dba-mba-pmp-cphq-0b50a572/ Website: poderohealth.com